Physician profile
Jooby Babu
NPI 1831374883
$4,423.79
in general payments reported to CMS, 2019-2025
28 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $930 · 2020: $247 · 2021: $513 · 2022: $762 · 2023: $1,243 · 2024: $430 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913 · Education: $57.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.41 |
| Education | $57.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $758.43 | 2019-2025 | Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $699.58 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Regeneron Healthcare Solutions, INC. | $557.37 | 2022-2025 | Dupixent |
| Philips North America LLC | $277.22 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Insmed, INC. | $245.28 | 2023-2024 | Arikayce |
| Inari Medical, INC. | $232.30 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $186.91 | 2019-2022 | |
| Intuitive Surgical, INC. | $176.97 | 2019 | |
| Mylan Specialty L.P. | $163.75 | 2021-2024 | Yupelri |
| Grifols USA, LLC | $156.66 | 2020-2025 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals Lp | $154.80 | 2019-2023 | Breztri |
| Allergan, INC. | $108.63 | 2019-2020 | |
| Gilead Sciences, INC. | $107.27 | 2021-2024 | |
| Genzyme Corporation | $105.35 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $104.66 | 2019-2024 | Xarelto |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $63.24 | 2019-2021 | |
| Pfizer INC. | $52.89 | 2022-2025 | |
| Baxter Healthcare | $48.67 | 2022 | |
| Advanced Respiratory, INC | $35.51 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.16 | 2020 | |
| C. R. Bard, INC. & Subsidiaries | $26.64 | 2025 | Arctic Sun 5000 |
| La Jolla Pharmaceutical Company | $23.72 | 2019 | |
| Abbvie INC. | $22.39 | 2023 | Avycaz |
| Edwards Lifesciences Corporation | $21.29 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi Pasteur INC. | $19.37 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.10 | 2021 | |
| Shionogi INC | $15.33 | 2021 | |
| Circassia INC. | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jooby Babu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.